Related Experiment Video
Updated: Oct 15, 2025

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy
Yajing Sun1,2, Qingshan Yang1,2, Xue Xia1,2
1Henan-Macquarie University Joint Centre for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng, China.
Frontiers in Bioengineering and Biotechnology
|October 25, 2021
Summary
Mitochondria-targeted polymeric nanoparticles offer a promising strategy to enhance cancer therapy by overcoming delivery challenges to these vital cellular organelles. This review explores their smart design and applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Cancer remains a significant global health threat despite medical advancements.
- Mitochondrial dysfunction is implicated in various diseases, including cancer.
- Targeting mitochondria offers a promising strategy for enhanced cancer therapy.
Purpose of the Study:
- To review the smart design of polymeric nanosystems for mitochondria targeting.
- To summarize current applications of these systems in improving cancer therapy.
Main Methods:
- Focus on polymeric nanoparticles as drug delivery vehicles.
- Discuss strategies for designing nanoparticles to target mitochondria.
- Review literature on the application of these targeted nanoparticles in cancer treatment.
Main Results:
- Polymeric nanoparticles offer advantages like biocompatibility and design flexibility for drug delivery.
- Mitochondria present unique challenges for therapeutic agent access due to their membrane system and potential.
- Smart design of polymeric nanosystems enables effective mitochondria targeting.
Conclusions:
- Mitochondria-targeted polymeric nanoparticles represent a key advancement in cancer therapy.
- Further development in nanosystem design can overcome mitochondrial delivery barriers.
- These targeted approaches hold significant potential for improving anticancer treatment efficacy.
Related Concept Videos
Electron Transport Chain: Complex I and II
15.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K

